Analysis of Toxicity and Efficacy of Subcutaneous Cladribine at Reduced or Standard Doses (Five Versus Seven Consecutive Days) In Patients with Hairy Cell Leukemia (HCL) In the ICGHCL2004 Protocol by the Italian Cooperative Group on HclFrancesco Forconi, Francesco Lauria, Francesca Fiore et al.|Blood|2010Cited by 8
Analysis of Parameters Predicting Treatment Efficacy and Outcome In Patients with Hairy Cell Leukemia (HCL) Receiving Subcutaneous Cladribine In the ICGHCL2004 Protocol (by the Italian Cooperative Group on HCL)Francesco Forconi, Francesco Lauria, Emanuele Cencini et al.|Blood|2010Cited by 0